Loading
Latest filing published 17 Sept 2026 for Hofseth BioCare ASA, €261k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Christoph Baldegger in Hofseth BioCare ASA. In total, 6 filings cover trades dated from 5 February 2021 to 17 September 2026.
On the market, this insider has only ever bought: 1 purchase, €261k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and no sales.
On 17 September 2026 came the latest disclosure, an open-market purchase for €261k in Hofseth BioCare ASA. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations